TDK Hutchinson Divests HTI Medical to Resonetics
TM Capital served as exclusive financial advisor to Hutchinson Technology, Inc., a subsidiary of TDK Corporation, in the sale of its medical division to Resonetics
TM Capital served as exclusive financial advisor to Hutchinson Technology, Inc., a subsidiary of TDK Corporation, in the sale of its medical division to Resonetics
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc.
TM Capital advised Surpass Medical, Ltd. in its sale to Stryker Corporation (NYSE:SYK) for $135 million in cash and future consideration
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected